RS-5186, a novel thromboxane synthetase inhibitor with a potent and extended duration of action

This publication has 27 references indexed in Scilit:

• Effects of γ-20811, a long-lasting thromboxane synthetase inhibitor, on thromboxane production and platelet function
  Thrombosis Research, 1986
• The biochemical pharmacology of thromboxane synthase inhibition in man.
  Circulation, 1985
• Inhibition of prostaglandin synthesis by sodium 2-[4-(2-oxocyclopentylmethyl)phenyl] propionate dihydrate (CS-600), a new anti-inflammatory drug, and its active metabolite in vitro and in vivo
  Biochemical Pharmacology, 1984
• Dazoxiben, a thromboxane synthetase inhibitor, in Raynaud's phenomenon
  Clinical Pharmacology & Therapeutics, 1984
• Effect of selective inhibitor of thromboxane A2 synthetase on cerebral vasospasm after early surgery
  Journal of Neurosurgery, 1984
• Effects of dazoxiben on exercise performance in chronic stable angina.
  British Journal of Clinical Pharmacology, 1983
• Beneficial effects of a new thromboxane synthetase inhibitor in arachidonate-induced sudden death
  Thrombosis Research, 1981
• A study of three vasodilating agents as selective inhibitors of thromboxane A2 biosynthesis
  Biochemical and Biophysical Research Communications, 1978
• Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides
  Prostaglandins, 1976
• Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides
  Nature, 1976